However, the effects of these HDACis on histone and nonhistone Kla need to be thoroughly investigated to develop novel anticancer therapeutic strategies because inhibiting HDACs may increase Kla, resulting in an unexpectedly poor prognosis in cancer treatment. This evidence concerns the gene KL and cancer.